The COVID-19 antibody responses, isotypes and glycosylation: Why SARS-CoV-2 Spike protein complex binding of IgG3 is potentiated in some and immuno-pathologies manifest

Raymond Kruse Iles
doi: https://doi.org/10.1101/2023.01.13.23284524

Article Information

doi 
https://doi.org/10.1101/2023.01.13.23284524
History 
  • January 13, 2023.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Raymond Kruse Iles1,*
  1. 1MAPSciences, The iLab, Stannard Way, Bedford, MK44 3RZ, UK
  1. ↵*corresponding author; email: rkiles{at}icloud.com
Back to top
Posted January 13, 2023.
Download PDF
Data/Code
Email
The COVID-19 antibody responses, isotypes and glycosylation: Why SARS-CoV-2 Spike protein complex binding of IgG3 is potentiated in some and immuno-pathologies manifest
Raymond Kruse Iles
medRxiv 2023.01.13.23284524; doi: https://doi.org/10.1101/2023.01.13.23284524
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area